As a member of resistin-like molecules (RELMs), which is a small family of secreted proteins associated with the activation of inflammatory [14], resistin can regulate inflammatory response, mediate metabolic disturbances and IR, promote cell proliferation, and enhance cancer progression [15], providing novel insights to obesity and colorectal cancer. The gene discussed is RETN; the disease is colorectal cancer.